CompletedNCT02922751

FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)

Studying Isolated biliary atresia

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Arbor Research Collaborative for Health
Principal Investigator: Benjamin Shneider, MD
Baylor College of Medicine
Intervention: Liver Stiffness Measurement (LSM)(other)
Enrollment: 552 enrolled
Eligibility: 21 years · All sexes
Timeline: 2016 – 2022

Study locations (13)

Children's Hospital Los Angeles, Los Angeles, California, United States
University of California at San Francisco (UCSF), San Francisco, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta (Emory University), Atlanta, Georgia, United States
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
Riley Hospital for Children, Indianapolis, Indiana, United States
Cincinnati Children's Memorial Hospital, Cincinnati, Ohio, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
Texas Children's Hospital (Baylor College of Medicine), Houston, Texas, United States
University of Utah, Salt Lake City, Utah, United States
Seattle Children's Hospital, Seattle, Washington, United States
Hospital for Sick Children, Toronto, Ontario, Canada

Collaborators

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02922751 on ClinicalTrials.gov

Other trials for Isolated biliary atresia

Additional recruiting or active studies for the same condition.

See all trials for Isolated biliary atresia →

← Back to all trials